2020
DOI: 10.1016/j.nbd.2019.104724
|View full text |Cite
|
Sign up to set email alerts
|

APOE in the normal brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
84
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 92 publications
(86 citation statements)
references
References 169 publications
2
84
0
Order By: Relevance
“…We focused on the comparison between individuals at standard genetic risk for AD (ε3ε3; hereafter non-carriers) and individuals at increased genetic risk for AD in heterozygosis (ε3ε4; hereafter; carriers) since sample sizes were insufficient to separately study the effects ε2 carriage (linked to reduced risk of AD but increased risk of type III hyperlipoproteinemia [24]) and ε4 carriage in homozygosis. Nevertheless, excluded genotypes are known to alter molecular and cellular dynamics [24,25], which could potentially interfere with the neurophysiological response to exercise, and therefore, we decided not to group together all ε4-carrying (ε2ε4, ε3ε4, ε4ε4) and all ε4-non-carrying (ε2ε2, ε2ε3, ε3ε3) genotypes. Among the remaining 127 participants, there were 36 APOE ε4 carriers and 91 non-carriers.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…We focused on the comparison between individuals at standard genetic risk for AD (ε3ε3; hereafter non-carriers) and individuals at increased genetic risk for AD in heterozygosis (ε3ε4; hereafter; carriers) since sample sizes were insufficient to separately study the effects ε2 carriage (linked to reduced risk of AD but increased risk of type III hyperlipoproteinemia [24]) and ε4 carriage in homozygosis. Nevertheless, excluded genotypes are known to alter molecular and cellular dynamics [24,25], which could potentially interfere with the neurophysiological response to exercise, and therefore, we decided not to group together all ε4-carrying (ε2ε4, ε3ε4, ε4ε4) and all ε4-non-carrying (ε2ε2, ε2ε3, ε3ε3) genotypes. Among the remaining 127 participants, there were 36 APOE ε4 carriers and 91 non-carriers.…”
Section: Methodsmentioning
confidence: 99%
“…Artifact-free data were segmented in 4 s epochs. Then, MEG time series were filtered into delta (2-4 Hz), theta (4-8 Hz), alpha (8)(9)(10)(11)(12), and beta (12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30). This procedure has been reported in detail in [22].…”
Section: Data Acquisition and Signal Preprocessingmentioning
confidence: 99%
“…Several studies have demonstrated that the APOE ε4 allele is an independent risk factor for Alzheimer's dementia (Strittmatter et al, 1993). Besides, the associations with the APOE have been observed in several other central nervous system diseases, such as dementia with Lewy bodies, recovery of stroke, and risk of cognitive impairment after chemotherapy (Flowers and Rebeck, 2020). However, the relationship between the APOE ε4 allele and vascular dementia is still controversial (Zekry et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, excluded genotypes are known to alter molecular and cellular dynamics (24,25), which could potentially interfere with the neurophysiological response to exercise and therefore we decided not to group together all ε4 carrying (ε2ε4, ε3ε4, ε4ε4) and all ε4 non-carrying carrying (ε2ε2, ε2ε3, ε3ε3) genotypes. Among the remaining 127 participants, there were 3 6 APOE ε4 carriers and 91 noncarriers.…”
Section: Methodsmentioning
confidence: 99%
“…Artifact-free data were segmented in 4 seconds epochs. Then MEG time series were filtered into delta (2-4Hz), theta (4-8Hz), alpha (8-12Hz) and beta (12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30). This procedure has been reported in detailed in (22).…”
Section: Magnetoencephalographymentioning
confidence: 99%